Masahiro Doi
Ube, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker of inflammatory activity in patients with cardiac sarcoidosis.
Journal: International journal of cardiology
Published: July 25, 2014
A low-dose β1-blocker effectively and safely slows the heart rate in patients with acute decompensated heart failure and rapid atrial fibrillation.
Journal: Cardiology
Published: June 03, 2013
Effects of isoproterenol infusion on the ST segment and r of the QRS complex in the right precordial leads of the Brugada-type electrocardiogram pattern--author's reply.
Journal: Journal of cardiology
Published: March 19, 2013
Enhanced binding of calmodulin to the ryanodine receptor corrects contractile dysfunction in failing hearts.
Journal: Cardiovascular research
Published: August 16, 2012
Low-dose β-blocker in combination with milrinone safely improves cardiac function and eliminates pulsus alternans in patients with acute decompensated heart failure.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: April 07, 2012
Characteristics of induced ventricular fibrillation cycle length in symptomatic Brugada syndrome patients.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: January 19, 2012
Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure.
Journal: Circulation journal : official journal of the Japanese Circulation Society
Published: October 20, 2011
Effects of isoproterenol and propranolol on the inducibility and frequency of ventricular fibrillation in patients with Brugada syndrome.
Journal: Journal of cardiology
Published: October 08, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026